The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2022
Filed:
Sep. 27, 2017
Applicant:
The Curators of the University of Missouri, Columbia, MO (US);
Inventors:
Raghuraman Kannan, Columbia, MO (US);
Charles Caldwell, Jr., Columbia, MO (US);
Vitukudi Narayanaiyengar Balaji, Columbia, MO (US);
Govardhan Aadharsh Balaji, Columbia, MO (US);
Assignee:
The Curators of the University of Missouri, Columbia, MO (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); G01N 33/533 (2006.01); G01N 33/574 (2006.01); G01N 33/52 (2006.01); G01N 33/53 (2006.01); G01N 33/60 (2006.01); C07K 1/13 (2006.01); C07K 14/705 (2006.01); A61K 49/00 (2006.01); A61K 51/08 (2006.01); G01N 15/14 (2006.01); G01N 33/535 (2006.01); G01N 33/58 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 49/0032 (2013.01); A61K 49/0056 (2013.01); A61K 51/08 (2013.01); C07K 1/13 (2013.01); C07K 14/70532 (2013.01); G01N 33/52 (2013.01); G01N 33/53 (2013.01); G01N 33/533 (2013.01); G01N 33/574 (2013.01); G01N 33/57492 (2013.01); G01N 33/60 (2013.01); C07K 2319/60 (2013.01); C07K 2319/74 (2013.01); G01N 15/14 (2013.01); G01N 33/535 (2013.01); G01N 33/582 (2013.01); G01N 2333/70532 (2013.01);
Abstract
This disclosure relates to synthetic ligands for detecting PD-L1 in a sample or subject. The ligand can be labeled with a variety of detectable labels allowing of visualization and quantification. The ligand provides an alternative PD-L1 binding molecule with advantages over current antibody technologies for detecting PD-L1.